Johnson & Johnson (JNJ)

Apr 18, 2025, 10:15 AM EDT - 2 days ago

Johnson & Johnson: 15% of AI Use Cases Deliver 80% of Value

Apr 18, 2025, 7:00 AM EDT - 2 days ago

Johnson & Johnson Pivots Its AI Strategy

Apr 17, 2025, 8:05 AM EDT - 3 days ago

Why Most Dividend Retirement Strategies Fail: How To Retire With Dividends

AEM BIP BIPC BIZD DIA EPD GLD

Apr 16, 2025, 4:28 PM EDT - 4 days ago

Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

Apr 16, 2025, 12:51 PM EDT - 4 days ago

Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffs

DXCM LLY

Apr 15, 2025, 3:00 PM EDT - 5 days ago

Two New Dividend Picks To Help You Navigate Tariffs And Uncertainty -- One Yields 7%+

AAPL ARE SCHD SCHO UL

Apr 15, 2025, 1:03 PM EDT - 5 days ago

Johnson & Johnson tops Wall Street expectations in Q1

Apr 15, 2025, 12:42 PM EDT - 5 days ago

Johnson & Johnson (JNJ) Q1 2025 Earnings Call Transcript

Apr 15, 2025, 11:06 AM EDT - 5 days ago

J&J Expects Tariffs to Cost Company $400 Million

Apr 15, 2025, 10:53 AM EDT - 5 days ago

Johnson & Johnson beats on top and bottom lines

Apr 15, 2025, 10:43 AM EDT - 5 days ago

Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves

Apr 15, 2025, 10:30 AM EDT - 5 days ago

JNJ Raises Guidance Despite Tariffs, ACI Guidance Slump, GM Downgrades

GM ACI

Apr 15, 2025, 8:11 AM EDT - 5 days ago

Johnson & Johnson raised its sales outlook, even with tariff costs included

Apr 15, 2025, 7:28 AM EDT - 5 days ago

Johnson & Johnson CFO on earnings: Guidance has 'a lot more than meets the eye'

Apr 15, 2025, 7:06 AM EDT - 5 days ago

Johnson & Johnson Tops Q1 Estimates, Lifts Full-Year Sales Outlook

Apr 15, 2025, 6:53 AM EDT - 5 days ago

J&J Increases Outlook After Beating 1Q Expectations

Apr 15, 2025, 6:23 AM EDT - 5 days ago

J&J beats Wall Street quarterly sales and profit estimates on cancer drug sales

Apr 15, 2025, 6:20 AM EDT - 5 days ago

Johnson & Johnson Reports Q1 2025 Results

Apr 15, 2025, 3:33 AM EDT - 5 days ago

Johnson & Johnson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Apr 14, 2025, 2:03 PM EDT - 6 days ago

Trump Says Pharmaceutical Tariffs Coming in Near Future

ABBV AMGN AZN BMY GSK IBB LLY

Apr 14, 2025, 12:26 PM EDT - 6 days ago

Trump says US pharma tariffs coming in not-too-distant future

ABBV AMGN AZN BMY GSK LLY MRK

Apr 14, 2025, 10:05 AM EDT - 6 days ago

Johnson & Johnson's Oral IL-23, Icotrokinra, Poised to Redefine the Psoriasis Treatment Landscape Following Positive Phase 3 Data, According to Spherix Global Insights

Apr 11, 2025, 6:56 PM EDT - 9 days ago

Jim Cramer's week ahead: Earnings from Goldman Sachs, Johnson & Johnson and Netflix

NFLX GS

Apr 11, 2025, 12:46 PM EDT - 9 days ago

Johnson & Johnson: Fairly Valued, But Recession-Resilient

Apr 11, 2025, 10:30 AM EDT - 9 days ago

Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

ABBV AMGN AZN BMY GSK IBB LLY

Apr 10, 2025, 8:05 AM EDT - 10 days ago

Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin and demonstrate favorable safety profile in a once daily pill

Apr 10, 2025, 4:45 AM EDT - 10 days ago

Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback

ABBV AMGN AZN BMY GSK LLY MRK

Apr 9, 2025, 6:32 PM EDT - 11 days ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK LLY MRK

Apr 9, 2025, 3:59 PM EDT - 11 days ago

Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out

ABBV AMGN AZN BMY GSK LLY MRK

Apr 9, 2025, 2:27 PM EDT - 11 days ago

Explainer: Prescription drugs become a target in Trump's trade war

ABBV AMGN AZN BMY GSK IBB LLY

Apr 9, 2025, 1:06 PM EDT - 11 days ago

Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

ABBV AMGN AZN BMY GSK IBB LLY

Apr 9, 2025, 11:53 AM EDT - 11 days ago

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs

ABBV AMGN AZN BMY GSK LLY MRK

Apr 9, 2025, 11:51 AM EDT - 11 days ago

Pharmaceutical stocks fall as Trump doubles down on tariffs threat

LLY ABBV AMGN AZN BMY GSK MRK

Apr 9, 2025, 11:49 AM EDT - 11 days ago

Why drug stocks are no longer a safe haven from the stock market's turmoil

ABBV AMGN BMY IBB LLY MRK PFE

Apr 9, 2025, 11:28 AM EDT - 11 days ago

This Johnson & Johnson Analyst Turns Bullish On Shifting Focus From Stelara Concerns To Innovative Medicine

Apr 9, 2025, 9:50 AM EDT - 11 days ago

S&P 500: Pharma Giants Lead Decline as Tariff Threats Rattle Pfizer, Merck, Johnson & Johnson

IVV MRK PFE SPLG SPXL SPY SSO

Apr 8, 2025, 10:19 AM EDT - 12 days ago

Cramer's Stop Trading: Johnson & Johnson

Apr 8, 2025, 5:38 AM EDT - 12 days ago

Johnson & Johnson highlights new data, demonstrating long-term sustained disease control in adults living with generalised myasthenia gravis (gMG)

Apr 8, 2025, 3:00 AM EDT - 12 days ago

Johnson & Johnson highlights new data that showcase the strength of nipocalimab, demonstrating long-term sustained disease control in adults living with generalized myasthenia gravis (gMG)

Apr 7, 2025, 4:25 PM EDT - 13 days ago

Johnson & Johnson to Participate in the BofA Securities 2025 Healthcare Conference

Apr 7, 2025, 12:51 PM EDT - 13 days ago

Market Weakness, A.I. Frenzy & Rebecca Walser's Picks: META, TTD, JNJ

META TTD

Apr 7, 2025, 5:32 AM EDT - 13 days ago

European Commission approves Johnson & Johnson's subcutaneous DARZALEX® (daratumumab)-based quadruplet regimen for the treatment of patients with newly diagnosed multiple myeloma, regardless of transplant eligibility

Apr 5, 2025, 8:00 AM EDT - 15 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (April 2025)

ACN ADM ADP AES AMH ARCC AVGO

Apr 4, 2025, 1:01 PM EDT - 16 days ago

1 Ideal Buy From 23 "Safer" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)

AXP BAC BLK DAL GS JPM JWN

Apr 4, 2025, 8:05 AM EDT - 16 days ago

TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs and symptoms and the progression of structural damage in adults living with active psoriatic arthritis

Apr 3, 2025, 2:15 PM EDT - 17 days ago

Potatoes, discount chains and drugmakers offer havens in stock-market bloodbath

ABBV CAG CHD CNC ELV GIS KHC

Apr 2, 2025, 12:26 PM EDT - 18 days ago

Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended

Apr 2, 2025, 8:44 AM EDT - 18 days ago

Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership

Apr 2, 2025, 7:30 AM EDT - 18 days ago

3 Wide-Moat Dividend Stars For A Championship Portfolio

DHR NEE

Apr 1, 2025, 5:31 PM EDT - 19 days ago

S&P 500 Gains and Losses Today: Johnson & Johnson Drops as Judge Rejects Liability Settlement